Injectable delivery systems are among the fastest-growing segments in the drug delivery devices market. The rise of biologic medicines, vaccines, insulin, and targeted therapies is increasing demand for syringes, infusion pumps, wearable injectors, and prefilled delivery systems. 1096

Syringes remain the largest device category, holding an estimated 43% share. Their importance spans vaccination, insulin delivery, emergency care, hospital treatment, and specialist-administered biologics. Prefilled syringe systems are gaining attention because they can reduce preparation steps and support dose consistency.

Cancer care is the fastest-growing therapeutic application. More personalized therapies and biologic medicines often require advanced delivery methods that can improve precision and treatment convenience.

Manufacturers are focused on needle-safety mechanisms, connected injection devices, reusable components, and sustainable packaging. As injectables become more common, device design will increasingly influence treatment experience and medication persistence.

Read more: Drug Delivery Devices Market 1096

FAQs

Q1. Why are injectable devices growing?
They are essential for many biologics, vaccines, insulin therapies, and targeted treatments.

Q2. What is a prefilled syringe?
It is a syringe supplied with a measured dose of medicine, designed to reduce preparation steps.

Tags: injectable drug delivery, prefilled syringes, biologic drug delivery, wearable injectors, cancer therapy devices